Although it is difficult to limit the outstanding multiple sclerosis research in 2019 to a selection of publications, the most important advances were made in the identification of sensitive biomarkers for predicting and monitoring disability progression. The use of MRI to estimate long-term disease progression in multiple sclerosis has previously yielded mixed results; however, new research using novel imaging strategies could bring new clarity.

中文翻译：

---

2019年多发性硬化症：预测进展。

尽管很难将2019年杰出的多发性硬化症研究限制在某些出版物上，但在识别用于预测和监测残疾进展的敏感生物标志物方面取得了最重要的进展。先前，使用MRI来估计多发性硬化症的长期疾病进展的结果好坏参半。但是，使用新颖的成像策略进行的新研究可能会带来新的清晰度。